Related Experiment Video
Updated: Jun 13, 2026
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Chitosan Oligosaccharides Suppress Adipogenesis and Lipid Accumulation in 3T3-L1 Preadipocytes via Multi-Pathway
Sineenart Songkoomkrong1,2, Siriporn Nonkhwao1,2, Jirawat Saetan3
1Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Pathumthani 12120, Thailand.
International Journal of Molecular Sciences
|June 12, 2026
Summary
Chitosan oligosaccharides (COS) effectively reduce fat accumulation and promote glucose uptake in cells. These natural compounds modulate key genes and pathways involved in obesity, showing potential for metabolic disorder treatments.
Area of Science:
- Biochemistry and Molecular Biology
- Nutritional Science
- Metabolic Research
Background:
- Obesity is a significant global health issue linked to type 2 diabetes, cardiovascular disease, and metabolic syndrome.
- Chitosan oligosaccharides (COS), derived from crustacean shells, show potential for natural anti-obesity effects.
- The precise molecular mechanisms of low-molecular-weight COS in regulating adipogenesis are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms by which structurally defined low-molecular-weight COS affects adipogenic transcription networks.
- To explore the global transcriptional reprogramming induced by COS in preadipocytes.
- To evaluate the anti-adipogenic and metabolic effects of COS in a cellular model.
Main Methods:
- Characterization of COS using MALDI-TOF mass spectrometry and 13C NMR spectroscopy.
- In vitro study using 3T3-L1 preadipocytes treated with varying concentrations of COS.
- Analysis of lipid accumulation, triglyceride content, lipolysis, and glucose uptake.
- Western blot analysis for adipogenic transcription factors (PPARγ, C/EBPα).
- Transcriptomic RNA-seq analysis to assess global gene expression changes.
Main Results:
- Low-molecular-weight COS, predominantly dimeric species (DP2), was identified.
- COS treatment dose-dependently reduced lipid accumulation, triglyceride content, and adipocyte maturation.
- COS enhanced lipolysis and insulin-mediated glucose uptake.
- Western blot revealed dose-dependent downregulation of PPARγ and C/EBPα.
- RNA-seq showed significant transcriptional reprogramming affecting PPAR signaling, PI3K-Akt, AMPK, insulin signaling, and fatty acid metabolism pathways.
Conclusions:
- COS effectively suppresses adipogenesis by modulating key adipogenic transcription factors.
- COS influences multiple metabolic signaling pathways involved in cellular metabolism.
- These findings support the potential of COS as a natural therapeutic agent for obesity and metabolic disorders, warranting further preclinical investigation.
